Wieslab Bioanalytical Services participates in the Outsourcing in Clinical Trials Europe 2016 meeting in Paris May 17 – 18.

May 12, 2016 - Company News
During the 2016 Outsourcing in Clinical Trials Europe, Wieslab Bioanalytical Services is exhibiting a range of Bioanalytical services for non-clinical as well as clinical and post-marketing studies for pharma, biotech, and CRO customers.

The two day conference offers the perfect platform for senior-level pharmaceutical and biotech companies from across Europe to come and meet us, learn about our CRO services, build partnerships and identify optimised operational strategies for their trials.

By offering bioanalytical services centered on large molecules (biologics and biosimilars) with a focus on immune-mediated diseases, our goal is to provide key knowledge and analytical results to help clients accelerate their drug discovery and development programs.

Our offering consists of:

  • Anti Drug Antibody testing  (ADA) in immunogenicity studies
  • Bioanalysis in pharmacokinetic (PK) studies
  • Analysis of biomarkers
  • CMC support for lot release of drugs (potency assays)

Visit us at booth 33 to learn more about our services and find out how we will be able to assist in your project.

Click here to read more about Outsourcing in Clinical Trials Europe 2016


« Back